A new trading day began on Tuesday, with Beta Bionics Inc (NASDAQ: BBNX) stock price up 4.84% from the previous day of trading, before settling in for the closing price of $27.49. BBNX’s price has ranged from $8.89 to $30.47 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 77.07%. With a float of $33.17 million, this company’s outstanding shares have now reached $43.99 million.
Beta Bionics Inc (BBNX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Beta Bionics Inc is 24.65%, while institutional ownership is 92.50%. The most recent insider transaction that took place on Oct 31 ’25, was worth 37,780. In this transaction Director of this company sold 1,406 shares at a rate of $26.87, taking the stock ownership to the 9,841 shares. Before that another transaction happened on Oct 31 ’25, when Company’s Director sold 1,406 for $26.91, making the entire transaction worth $37,834. This insider now owns 9,841 shares in total.
Beta Bionics Inc (BBNX) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -2.72 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.07% per share during the next fiscal year.
Beta Bionics Inc (NASDAQ: BBNX) Trading Performance Indicators
Here are Beta Bionics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 9.83. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.80 in one year’s time.
Technical Analysis of Beta Bionics Inc (BBNX)
Compared to the last year’s volume of 0.61 million, its volume of 0.69 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 59.16%.
During the past 100 days, Beta Bionics Inc’s (BBNX) raw stochastic average was set at 90.94%, which indicates a significant increase from 85.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.18 in the past 14 days, which was higher than the 1.36 volatility it showed in the past 100 days.
Nevertheless, the first resistance level for the watch stands at $30.05 in the near term. At $31.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $32.97. If the price goes on to break the first support level at $27.13, it is likely to go to the next support level at $25.43. Now, if the price goes above the second support level, the third support stands at $24.20.
Beta Bionics Inc (NASDAQ: BBNX) Key Stats
With a market capitalization of 1.27 billion, the company has a total of 44,025K Shares Outstanding. Currently, annual sales are 65,120 K while annual income is -54,760 K. The company’s previous quarter sales were 27,250 K while its latest quarter income was -14,210 K.
